Ligand Pharmaceuticals (LGND) Prepaid Assets (2010 - 2026)
Ligand Pharmaceuticals (LGND) reported Prepaid Assets of $5.8 million for Q1 2026, down 56.38% on a YoY basis from $13.3 million in Q1 2025, and little changed sequentially from $5.8 million in Q4 2025.
Ligand Pharmaceuticals (LGND) Prepaid Assets (2010 - 2026) Analysis & Trends
Ligand Pharmaceuticals (LGND) has 17 years of Prepaid Assets data on file, last reported at $5.8 million in Q1 2026.
- For the quarter ending Q1 2026, Prepaid Assets fell 56.38% year-over-year to $5.8 million; the trailing twelve-month figure through Mar 2026 stood at $5.8 million (down 56.38% YoY), and the FY2025 full-year result was $5.8 million, down 34.31% from the prior year.
- Prepaid Assets steadied at $5.8 million in Q1 2026, from $5.8 million in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $19.7 million in Q3 2024 to a low of $1.1 million in Q4 2022.
- A 5-year average of $6.7 million and a median of $5.8 million in 2026 frame the typical range for Prepaid Assets.
- Across the five-year window, Prepaid Assets tumbled 80.49% in 2023 and soared 841.39% in 2024, its largest moves.
- Tracing LGND's Prepaid Assets over 5 years: stood at $1.1 million in 2022, then surged by 134.72% to $2.7 million in 2023, then surged by 231.43% to $8.8 million in 2024, then tumbled by 34.31% to $5.8 million in 2025, then advanced by 0.17% to $5.8 million in 2026.
- Business Quant data shows LGND's Prepaid Assets at $5.8 million in Q1 2026, $5.8 million in Q4 2025, and $7.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Ligand Pharmaceuticals | 6.05 Bn | 5.27 Bn | 48.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.80 Mn |
| Dec 31, 2025 | 5.79 Mn |
| Sep 30, 2025 | 6.99 Mn |
| Jun 30, 2025 | 4.82 Mn |
| Mar 31, 2025 | 13.29 Mn |
| Dec 31, 2024 | 8.81 Mn |
| Sep 30, 2024 | 19.74 Mn |
| Jun 30, 2024 | 7.12 Mn |
| Mar 31, 2024 | 7.31 Mn |
| Dec 31, 2023 | 2.66 Mn |
| Sep 30, 2023 | 2.10 Mn |
| Jun 30, 2023 | 2.77 Mn |
| Mar 31, 2023 | 2.33 Mn |
| Dec 31, 2022 | 1.13 Mn |
| Sep 30, 2022 | 10.75 Mn |
| Jun 30, 2022 | 7.80 Mn |
| Mar 31, 2022 | 4.66 Mn |
| Dec 31, 2021 | 3.57 Mn |
| Sep 30, 2021 | 5.16 Mn |
| Jun 30, 2021 | 6.27 Mn |